Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-11-07

FDA Approved: FOSCAVIR — Supplemental Application (Clinigen Limited)

View source ↗

Summary

The FDA approved a supplemental application for FOSCAVIR (foscarnet sodium) from Clinigen Limited, authorizing changes to the product labeling. The action confi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FOSCAVIR (foscarnet sodium)

Snippet

SUPPL AP for FOSCAVIR (FOSCARNET SODIUM)